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Editorial
There is a growing incidence (20-50%) of Post-Operative Atrial Fibrillation (POAF) after 
cardiac and lung surgeries around the globe [1,2]. These events often result in increased morbidity, 
thromboembolisms, strokes, and long-term mortality causing recurring hospitalizations and 
increased costs. Often the cause(s) of POAF is not known. Age, previous history of Atrial 
Fibrillation (AF), hypertension, diabetes, myocardial infarction, valvular heart disease, left 
ventricular hypertrophy, obesity, excessive drinking of alcohol and excessive smoking present 
great risk factors for development of POAF [1,2]. According to a number of autopsy reports, the 
incidence of considerable atherosclerotic plaques on the walls of the coronary blood vessels is very 
significant leading to the idea that inflammatory events, over years, play an important role in the 
PAOF syndrome. Several studies have suggested that use of intravenous magnesium (Mg) may yield 
better beneficial results than either beta-blockers, calcium channel blockers, digoxin and cardiac 
glycosides, or amiodarone [1,3,4].
Mg is a co-factor for more than 500 enzymes, and is the second most abundant intracellular 
cation after potassium. It is pivotal in numerous pathophysiological, cellular, and biochemical 
functions necessary for life [5-7].
Approximately 40 years ago, our laboratories suggested a progressive, dietary deficiency and/
or metabolically-induced loss of Mg from the body (and heart), particularly the coronary vascular 
tree, could lead to coronary arterial spasms, arrhythmias, and sudden-cardiac death (SCD) [8,9]. 
Ever since we published these works, a number of clinical studies have been done which support 
our hypothesis, at least in adults, irrespective of gender [10]. It is well-known that disturbances 
in diet can produce inflammatory lesions, promote lipid deposition and accelerated growth, and 
transformation of the smooth muscle cells in the vascular walls [11]. Our group, over a period of 
many years, has demonstrated, experimentally, that reduction in dietary intake of Mg can result 
in hypertension, atherogenesis on coronary and peripheral blood vessels , cardiac dysfunctions, 
inflammations and strokes of diverse types [10,12-14]; most of these phenomena being observed in 
patients scheduled for cardiac and lung surgeries [1-4].
In the Western World, dietary intake of Mg is subnormal, with short falls of between 65 and 225 
mg of Mg/day, depending upon geographic region [5,6,8,10,13]. However, in the elderly population, 
those being the greater population needing cardiac and lung surgeries, the shortfalls in daily Mg 
intake often approach 100-275 mg of Mg/day. Newly compiled NHANES data indicate that 65% 
of the American population is Mg deficient. Added to this, one must recognize that most drinking 
waters are low in Mg, particularly in soft-water areas, and that many geographic areas have Mg-
poor soil contents. Most of the soft-water and Mg-poor soil contents of Mg are associated with 
high incidences of Ischemic Heart Disease (IHD), severe atherosclerosis, coronary vasospasm, 
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hypertension, hyperlipidemia, and SCD [5-7,10]. The myocardial 
level of Mg, where autopsy data is available, has consistently been 
observed to be significantly lower in subjects dying from IHD and 
SCD, particularly in soft-water and Mg poor-soil regions around the 
globe [5,6,8,10].
Over the past two decades, our laboratories have helped to pioneer 
the development and use of sensitive, specific Mg2+-ion electrodes 
[14,15]. Use of these Mg2+-specific electrodes by our group has 
revealed that patients with IHD, and scheduled for cardiac surgery 
or lung surgery, as well patients in cardiac failure, and patients with 
severe atherosclerosis exhibit significant depletion of serum/plasma/
whole blood levels of Mg2+, but not necessarily total serum/plasma Mg 
[13-15]. In addition, we have shown that controlled dietary deficiency 
of Mg in laboratory rats and rabbits cause vascular remodeling 
concomitant with multiple areas of inflammation, atherogenesis, 
apoptosis, and hypertension( e.g., arteriolar wall hypertrophy and 
alterations in arterial wall matrices) of unknown origin [10].
Using a variety of new physical, biochemical, and biophysical 
techniques, our laboratories have recently found that Mg deficiency 
in intact animals and in isolated vascular smooth muscle (VSM) cells 
(subjected to primary cell culture) demonstrate an upregulation of 
all five major enzymatic pathways leading to synthesis and release 
of ceramides and other sphingolipid molecules in cardiac and 
VSM cells [10,13,16,17]. Ceramides and several other sphingolipid 
molecules are now known to be pivotal in fundamental processes 
such as inflammation, apoptosis, angiogenesis, atherosclerosis, 
excitation-contraction coupling events in VSM cells, cell adhesion 
events, immunogenic events, membrane-receptor functions, and 
microcirculatory functions [13,16,17]. Besides the findings that Mg-
Deficient Diets (MgDD) lead to synthesis and release of ceramides 
coupled to increased levels of calcium [10,13,16,17 ], we found that 
MgDD result in upregulation of a variety of cytokines, chemokines, 
proto-oncogenes, generation of a number of reactive oxygen-and 
nitrogen-species, upregulation of protein kinases of diverse types, 
activation of caspases, activation of nuclear factor-kB (NF-kB), 
mitochondrial release of cytchrome C, release of mitochondrial 
protease factor-1, alterations in a number of cellular phospholipids, 
DNA oxidation and fragmentation, lipid peroxidation, and 
downregulation of telomerases [10,13,16,17]. All of these events are 
now known to play important roles in cardiovascular atherogenesis, 
inflammation, morbidity and mortality; Mg deficiency being able 
to cause and promote these entire cellular and biochemical events. 
It is important to note, here, that we have found use of specific 
inhibitors of ceramide release and synthesis either prevented or 
greatly ameliorated the cellular, biochemical and molecular changes 
indicated in the above in MgD animals, tissues, and cells [10,13,16,17].
It is our belief that, collectively, these new studies on hearts, 
coronary arteries and peripheral blood vessels from animals on MgD 
diets support our hypothesis that generation and release of ceramides 
are pivotal molecules in the initiation of cellular and molecular 
events leading to coronary (and coronary microcirculatory) ischemic 
changes eventuating in inflammatory and atherogenic events 
producing atrial arrhythmias and fibrillation. However, many of 
these events, on the basis of recent studies in our laboratories, appear 
to be dependent upon the rapid synthesis of another molecule, viz., 
platelet-activating factor (PAF) [10].
In 1997, using proton -nuclear magnetic resonance spectroscopy 
we noted rapid formation of PAF and other PAF-like molecules 
in VSM cells in culture [18]. PAF is known to play important 
roles in inflammatory events and atherogenesis [19]. PAF has 
been demonstrated to affect the heart and cardiac muscle cells in 
diverse ways [19]. For example, PAF is known to induce coronary 
vasoconstriction, reduce arterial blood pressure, increase coronary 
vascular resistance, decrease stroke volume, reduce cardiac output, 
decrease cardiac contractility, alter cardiac atrial and papillary 
chronotropicity and membrane potentials, as well as alter potassium 
currents in isolated cardiomyocytes [19]. In addition, PAF can release 
a variety of vasoactive lipids from the myocardium [19]. Obviously, all 
of these attributes of PAF's actions on the heart, in themselves, could 
be more than enough to promote profound atrial fibrillation. It must 
also be remembered that PAF is known to be elaborated by a variety 
of circulating blood formed elements such as polymorphonuclear 
leukocytes, platelets, basophils, and macrophages as well as 
endothelial cells [19]. Importantly, we have recently demonstrated 
that Mg deficiency results in elaboration and release of PAF from 
coronary, cerebral, and peripheral VSM cells [10]. In addition, 
we have found that initiation of PAF release from these VSM cells 
results in synthesis and release of ceramides [10]. In addition, there 
are a growing number of reports that indicate that both PAF and 
ceramides can induce transformation of VSM cells from contractile 
cells to synthetic, non-contractile cells which elaborate a variety of 
growth factors, as observed in the atherogenic process [10,19 ]. In this 
context, our group has clearly demonstrated that MgDD in rabbits 
and rats can result in atherogenesis with adherence of leukocytes, 
platelets, and macrophages on the vascular walls [20]. Concomitant 
with these actions, using intravital study of the lung, muscle, and 
cutaneous microvessels, we have recently reported that increasing 
concentrations of PAF will result in intense leukocyte rolling, 
increased adherence of leukocytes and platelets to the endothelial 
surfaces of the postcapillary microvessels along with vasoconstriction 
and increases in permeability of the postcapillary microvessels 
[12, unpublished findings ]. Interestingly, we have reported that 
introduction of several different ceramides causes similar events to 
take place in these microvascular beds, as observed in-vivo by high-
power, quantitative TV–microscopy [10]. Collectively, it is our belief 
that these new studies could be used to advance our hypothesis that 
generation and release of both PAF and ceramides in the presence 
of an underlying Mg deficiency are more than likely involved in 
generation of atrial fibrillation after cardiac and lung surgery and are, 
most likely, major contributors in other types of patients presenting 
with atrial fibrillation.
In view of the above, we are of the belief that a clinical trial 
study should be initiated to determine ionized Mg levels, ceramide 
levels, and PAF levels prior to and after cardiac and lung surgeries 
in order to demonstrate any possible correlations between these 
parameters before (and after surgeries) to frequency of PAOF. It 
might also be prudent to initiate a clinical trial to determine whether 
patients scheduled for cardiac and lung surgeries would benefit from 
pretreatment with selective blockers of ceramide generation/ release 
and PAF generation/release along with administration of intravenous 
Mg.
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